We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Xi'an Tianlong Science & Technology Co., Ltd

Tianlong is an innovative, high-technology company that provides professional PCR detection devices, reagent kits and... read more Featured Products: More products

Download Mobile App




Tianlong was Showcased in the METROLOGIA LAB SUMMIT and the SBBQ 53rd Annual Meeting in Brazil with Integrated PCR Lab Solutions

By LabMedica International staff writers
Posted on 01 Jun 2024

In May 2024, Tianlong was honored with invitations to partake in a series of events including METROLOGIA LAB SUMMIT and the SBBQ 53rd Annual Meeting in Brazil with the primary focus of showcasing Tianlong and its innovative solutions and services.

Notably, Tianlong was also invited to deliver a speech at the renowned SBBQ 53rd Annual Meeting, one of Brazil's most traditional scientific events, hosted by the Brazilian Society of Biochemistry and Molecular Biology. More...

Ana Casali, Tianlong’s Business Development Manager based in Brazil, was invited as a distinguished speaker, delivering valuable insights about the new perspectives for life sciences professionals, as well as her expertise in technological innovation and professional development.

Tianlong offers an extensive array of products designed to meet the diverse needs of the molecular diagnostics field. From nucleic acid extractors utilizing the magnetic beads method to PCR thermal cyclers and real-time PCR systems, Tianlong ensures that laboratories have access to state-of-the-art equipment. Their products, which include automatic nucleic acid workstations and hundreds of compatible kits for extraction and detection, are integral to advancements in diagnostics, genomics research, and disease detection.

These collaborative engagements highlight Tianlong's dedication to innovation and industry leadership, as well as our significant presence and contributions to the scientific community in Brazil and beyond.

Related Links:
Tianlong


New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.